Abnormal Tau phosphorylation could be caused by decreased O-GlcNAcylation, which again could be linked to the metabolic alterations/deficiencies observed in AD and other neurodegenerative disorders, underlying the potential role of glycosylation in disease progression (Liu et al., 2004; Zhu et al., 2014). This evidence concerns the gene MAPT and Alzheimer disease.